Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

What Sparked Serina Therapeutics (SER) 35% After-Hours Surge? - Serina Therapeutics (AMEX:SER)

Summary by Benzinga
Serina Therapeutics shares jumped nearly 35% after the FDA cleared its IND application for SER-252, advancing plans for a Phase 1b trial in advanced Parkinson's disease.

2 Articles

BenzingaBenzinga
Center

What Sparked Serina Therapeutics (SER) 35% After-Hours Surge? - Serina Therapeutics (AMEX:SER)

Serina Therapeutics shares jumped nearly 35% after the FDA cleared its IND application for SER-252, advancing plans for a Phase 1b trial in advanced Parkinson's disease.

·New York, United States
Read Full Article
BizTocBizToc

What Sparked Serina Therapeutics (SER) 35% After-Hours Surge?

Serina Therapeutics Inc. (NYSEAMERICAN: SER) shares jumped 34.93% to $3.67 in after-hours trading on Wednesday after Food and Drug Administration cleared its Investigational New Drug application for SER-252, an investigational therapy for advanced Parkinson’s disease. Before the announcement, the…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Benzinga broke the news in New York, United States on Thursday, January 29, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

FDA icon

FDA

Parkinson's Disease icon

Parkinson's Disease

United States icon

United States

Health & Medicine icon

Health & Medicine

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal